Cargando…
The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target
NF-κB transcription factors are major drivers of tumor initiation and progression. NF-κB signaling is constitutively activated by genetic alterations or environmental signals in many human cancers, where it contributes to almost all hallmarks of malignancy, including sustained proliferation, cell de...
Autores principales: | Verzella, Daniela, Cornice, Jessica, Arboretto, Paola, Vecchiotti, Davide, Di Vito Nolfi, Mauro, Capece, Daria, Zazzeroni, Francesca, Franzoso, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496094/ https://www.ncbi.nlm.nih.gov/pubmed/36140335 http://dx.doi.org/10.3390/biomedicines10092233 |
Ejemplares similares
-
NF-κB: A Druggable Target in Acute Myeloid Leukemia
por: Di Francesco, Barbara, et al.
Publicado: (2022) -
Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer
por: Vecchiotti, Davide, et al.
Publicado: (2022) -
EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?
por: Di Vito Nolfi, Mauro, et al.
Publicado: (2022) -
Life, death, and autophagy in cancer: NF-κB turns up everywhere
por: Verzella, Daniela, et al.
Publicado: (2020) -
Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression
por: Flati, Irene, et al.
Publicado: (2023)